Print Page  Close Window

SEC Filings

S-8 POS
VITAE PHARMACEUTICALS, INC filed this Form S-8 POS on 10/25/2016
Entire Document
 

 

As filed with the Securities and Exchange Commission on October 25, 2016

 

Registration No. 333-200449

333-204625

333-209959

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

POST-EFFECTIVE AMENDMENTS

 

TO FORM S-8

 

REGISTRATION STATEMENTS

Under

The Securities Act of 1933

 


 

Vitae Pharmaceuticals, Inc.

(Exact name of Registrant as specified in its charter)

 


 

Delaware

 

04-3567753

(State or Other Jurisdiction of
Incorporation or Organization)

 

(I.R.S. Employer
Identification No.)

 

502 West Office Center Drive
Fort Washington, PA 19034

(215) 461-2000

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

 


 

2014 Equity Incentive Plan

2014 Employee Stock Purchase Plan

2013 Stock Plan

2004 Stock Plan
2001 Stock Plan

(Full title of plans)

 


 

A. Robert D. Bailey, Esq.

President

Vitae Pharmaceuticals, Inc.

c/o Allergan, Inc.

Morris Corporate Center III

400 Interpace Parkway

Parsippany, NJ 07054

(862) 261-7000

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 


 

Please send copies of all communications to:

 

Andrew L. Bab, Esq.

Debevoise & Plimpton LLP

919 Third Avenue

New York, NY 10022

(212) 909-6323

 


 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

o

 

Accelerated filer

 

x

 

 

 

 

 

 

 

Non-accelerated filer

 

o (Do not check if a smaller reporting company)

 

Smaller reporting company

 

o